An International, Multicenter, Openlabel, Randomized, Phase 3 Study of BLU285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

Project: Research

StatusActive
Effective start/end date12/02/1911/02/24